INTRACOASTAL CAPITAL, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for PharmaCyte Biotech, Inc.

Filing Manager: INTRACOASTAL CAPITAL, LLC
Reporting Manager: Mitchell P. Kopin
Security: PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share
Shares outstanding: 7.16M shares
Disclosed Ownership: 715K shares
Ownership: 9.99%
Form type: SCHEDULE 13G/A
Date filed: 1/15/2025, 04:03 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title
Mitchell P. Kopin	9.99%	715K	0	715K	/s/ Mitchell P. Kopin	Mitchell P. Kopin
Daniel B. Asher	9.99%	706K	82.7K	623K	/s/ Daniel B. Asher	Daniel B. Asher
Intracoastal Capital LLC	9.99%	715K	0	715K	/s/ Mitchell P. Kopin	Mitchell P. Kopin, Manager